Whole Exome Sequencing, Targeted plus Mitochondrial Genome

GenoLife

Delivery time

No especificado

Sample

No especificado

1.704,00€

Mass sequencing technology is most cost-effective when several similar diseases with different related genes are suspected.
Technique: Next-generation sequencing (NGS). The Novaseq 6000® system is used with the SureSelect V6 sequencing panel, and Nextera XT (NGS) is used for the mitochondrial genome.

Other tests

NGS-SEQ+CNVs - POLYPOSIUM SYNDROME-COLORECTAL CANCER

NGS-SEQ+CNVs - POLYPOSIUM SYNDROME-COLORECTAL CANCER

510,00€

NGS-SEQ+CNVs - SLE-LIKE SYNDROME

NGS-SEQ+CNVs - SLE-LIKE SYNDROME

520,00€

NGS-SEQ+CNVs - IMMUNODEFICIENCY SYNDROMES

NGS-SEQ+CNVs - IMMUNODEFICIENCY SYNDROMES

650,00€